Efficacy of Intravenous Chlorothiazide for Refractory Acute Decompensated Heart Failure Unresponsive to Adjunct Metolazone

Pharmacotherapy

Volumn 36, Issue 8, 2016, Pages 843-851

  Cardinale, Maria ^a,b   Altshuler, Jerry ^c   Testani, Jeffrey M ^d  

^a SAINT PETER S UNIVERSITY HOSPITAL   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c BETH ISRAEL MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

chlorothiazide; congestive heart failure; diuretic; metolazone; thiazide

Indexed keywords

CHLOROTHIAZIDE; METOLAZONE;

ACUTE HEART FAILURE; AGED; ARTICLE; CAUCASIAN; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIURESIS; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; MALE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; TREATMENT RESPONSE; URINE VOLUME;

EID: 84983036494     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1787     Document Type: Article

References (44)

1. Mozaffarian D, Benjamin EJ, Go AS, et al.; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics – 2015 update: a report from the American Heart Association. Circulation. 2015; 131:e29–322.
2. Cook C, Cole G, Asaria P, Jabbour R, Francis DP. The Annual Global Economic Burden of Heart Failure. Int J Cardiol 2014;171(3):368–76.
3. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;128:e240–327.
4. Donlan SM, Quattromani E, Pang PS, Gheorghiade M. Therapy for Acute Heart Failure Syndromes. Curr Cardiol Rep 2009;11(3):192–201.
5. Maze R, Haddad H. An Update in the Management of Acute Decompensated Heart Failure. Curr Opin Cardiol 2014;29(2):180–4.
6. Mentz RJ, Kjeldsen K, Rossi GP, et al. Decongestion in Acute Heart Failure. Eur J Heart Fail 2014;16(5):471–82.
7. Munoz D, Felker GM. Approaches to Decongestion in Patients with Acute Decompensated Heart Failure. Curr Cardiol Rep 2012;59(24):2145–53.
8. Koniari K, Parissis J, Paraskevaidis I, Anastasiou-Nana M. Treating Volume Overload in Acutely Decompensated Heart Failure: established and Novel Therapeutic Approaches. Eur Heart J Acute Cardiovasc Care 2012;1(3):256–68.
9. Chiong JR, Cheung RJ. Loop Diuretic Therapy in Heart Failure: the Need for Solid Evidence on a Fluid Issue. Clin Cardiol 2010;33(6):345–52.
10. Tuy T, Peacock WF. Fluid Overload Assessment and Management in Heart Failure Patients. Semin Nephrol 2012;32(1):112–20.
11. Peacock WF, Costanzo MR, De MT, et al. ADHERE Scientific Advisory Committee and Investigators. Impact of Intravenous Loop Diuretics on Outcomes of Patients Hospitalized with Acute Decompensated Heart Failure: insights From the ADHERE Registry. Cardiology 2009;113(1):12–9.
12. Brater DC. Diuretic Therapy. N Engl J Med 1998;339(6):387–95.
13. Cox ZL, Lenihan DJ. Loop Diuretic Resistance in Heart Failure: resistance Etiology-Based Strategies to Restoring Diuretic Efficacy. J Card Fail 2014;20(8):611–22.
14. Dormans TPJ, Gerlag PGG. Combination of High-Dose Furosemide and Hydrochlorothiazide in the Treatment of Refractory Congestive Heart Failure. Eur Heart J 1996;17(12):1867–74.
15. Shchekochikhin D, Al AF, Lindenfeld J, Schrier R. Role of Diuretics and Ultrafiltration in Congestive Heart Failure. Pharmaceuticals (Basel) 2013;6(7):851–66.
16. Jentzer JC, DeWald TA, Hernandez AF. Combination of Loop Diuretics With Thiazide-Type Diuretics in Heart Failure. J Am Coll Cardiol 2010;56:1527–34.
17. Dormans TP, Gerlag PG, Russel FG, Smits P. Combination Diuretic Therapy in Severe Congestive Heart Failure. Drugs 1998;55(2):165–72.
18. Sica DA, Gehr TWB. Diuretic Combinations in Refractory Oedema States. Clin Pharmacokinet 1996;30(3):229–49.
19. Wollam GL, Tarazi RC, Bravo EL, Dustan HP. Diuretic Potency of Combined Hydrochlorothiazide and Furosemide Therapy in Patients with Azotemia. Am J Med 1982;72(6):929–38.
20. Brater DC, Pressley RH, Anderson SA. Mechanisms of the Synergistic Combination of Metolazone and Bumetanide. J Pharmacol Exp Ther 1985;233(1):70–4.
21. Knauf H, Mutschler E. Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure. J Cardiovasc Pharmacol 1995;26:394–400.
22. Tanaka M, Oida E, Nomura K, et al. The Na+- excreting efficacy of indapamide in combination with furosemide in massive edema. Clin Exp Nephrol 2005;9:122–6.
23. Fliser D, Schröter M, Neubeck M, Ritz E. Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure. Kidney Int 1994;46:482–8.
24. Greenberg A, Wallia R, Puschett JB. Combined Effect of Bumetanide and Metolazone in Normal Volunteers. J Clin Pharmacol 1985;25(5):369–73.
25. Asscher AW. Treatment of furosemide resistant edema with metolazone. Clin Trials J 1974;4:134–9.
26. Gunstone RF, Wing AJ, Shani HGP, et al. Clinical experience with metolazone in fifty-two African patients: synergy with frusemide. Postgrad Med J 1971;47:789–93.
27. Ghose RR, Gupta SK. Synergistic action of metolazone with “loop” diuretics. Br Med J 1981;282:1432–3.
28. Kiyingi A, Field MJ, Pawsey CC, Yiannikas J, Lawrence JR, Arter WJ. Metolazone in treatment of severe refractory congestive cardiac failure. Lancet 1990;335:29–31.
29. Channer KS, McLean KA, Lawson-Matthew P, Richardson M. Combination Diuretic Treatment in Severe Heart Failure: a Randomised Controlled Trial. Br Heart J Feb. 1994;71(2):146–50.
30. Olesen KH, Dupont B, Flensted-Jensen E. The combined diuretic action of quinethazone and furosemide in congestive heart failure. Acta Med Scand 1970;187:33–40.
31. Olesen KH, Sigurd B. The supra-additive natriuretic effect addition of quinethazine or bendroflumethiazide during long-term treatment with furosemide and spironolactone. Permutation trial tests in patients with congestive heart failure. Acta Med Scand 1971;190:233–40.
32. Sigurd B, Olesen KH, Wennevold A. The supra-additive natriuretic effect addition of bendroflumethiazide and bumetanide in congestive heart failure. Permutation trial tests in patients in long-term treatment with bumetanide. Am Heart J 1975;89:163–70.
33. Grosskopf I, Rabinovitz M, Rosenfeld JB. Combination of furosemide and metolazone in the treatment of severe congestive heart failure. Isr J Med Sci 1986;22:787–90.
34. Aravot DJ, Banner NR, Musumeci F, et al. Oral metolazone plus frusemide for home therapy in patients with refractory heart failure. Lancet 1989;333:727.
35. Channer KS, Richardson M, Crook R, Jones JV. Thiazides with loop diuretics for severe congestive heart failure. Lancet 1990;335:922–3.
36. Mouallem M, Brif I, Mayan H, Farfel Z. Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions. Int J Cardiol 1995;50:89–94.
37. Dormans TPJ, Gerlag PG. Combination of high-dose furosemide and hydrochlorothiazide in the treatment of refractory congestive heart failure. Eur Heart J 1996;17:1867–74.
38. Vanky F, Broquist M, Svedjeholm R. Addition of a thiazide: an effective remedy for furosemide resistance after cardiac operations. Ann Thorac Surg 1997;63:993–7.
39. Rosenberg J, Gustafsson F, Galatius S, Hildebrandt PR. Combination therapy with metolazone and loop diuretics in outpatients with refractory heart failure: an observational study and review of the literature. Cardiovasc Drugs Ther 2005;19:301–6.
40. Kissling KT, Pickworth KK. Comparison of the Effects of Combination Diuretic Therapy with Oral Hydrochlorothiazide or Intravenous Chlorothiazide in Patients Receiving Intravenous Furosemide Therapy for the Treatment of Heart Failure. Pharmacotherapy 2014;34(8):882–7.
41. Moranville MP, Choi S, Hogg J, Anderson AS, Rich JD. Comparison of metolazone versus chlorothiazide in acute decompensated heart failure with diuretic resistance. Cardiovasc Ther 2015;33(2):42–9.
42. Zaroxolyn [Package Insert]. Sanofi-Aventis Canada, Inc: Laval, Quebec, Canada; 2006.
43. Testani JM, Brisco MA, Kociol RD, et al. Substantial Discrepancy Between Fluid and Weight Loss During Acute Decompensated Heart Failure Treatment. Am J Med 2015;128(7):776–83.
44. Redbook Online [online database]. Greenwood Village, CO: Truven Health Analytics. Accessed June 14, 2016.